BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21364580)

  • 1. Expression of NRG1 and its receptors in human bladder cancer.
    Forster JA; Paul AB; Harnden P; Knowles MA
    Br J Cancer; 2011 Mar; 104(7):1135-43. PubMed ID: 21364580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.
    Bei R; Pompa G; Vitolo D; Moriconi E; Ciocci L; Quaranta M; Frati L; Kraus MH; Muraro R
    J Pathol; 2001 Oct; 195(3):343-8. PubMed ID: 11673832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
    Chow NH; Chan SH; Tzai TS; Ho CL; Liu HS
    Clin Cancer Res; 2001 Jul; 7(7):1957-62. PubMed ID: 11448910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.
    Shin DH; Jo JY; Han JY
    Mol Cancer Ther; 2018 Sep; 17(9):2024-2033. PubMed ID: 29959202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
    Stindt S; Cebula P; Albrecht U; Keitel V; Schulte am Esch J; Knoefel WT; Bartenschlager R; Häussinger D; Bode JG
    PLoS One; 2016; 11(2):e0148711. PubMed ID: 26886748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
    Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
    Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
    Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
    Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus.
    Wang XD; Su YA; Guo CM; Yang Y; Si TM
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):553-61. PubMed ID: 18184445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.
    Zhang K; Wong P; Duan J; Jacobs B; Borden EC; Bedogni B
    Pigment Cell Melanoma Res; 2013 May; 26(3):408-14. PubMed ID: 23480537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects.
    Polosa R; Puddicombe SM; Krishna MT; Tuck AB; Howarth PH; Holgate ST; Davies DE
    J Allergy Clin Immunol; 2002 Jan; 109(1):75-81. PubMed ID: 11799369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder.
    Amsellem-Ouazana D; Bièche I; Tozlu S; Botto H; Debré B; Lidereau R
    J Urol; 2006 Mar; 175(3 Pt 1):1127-32. PubMed ID: 16469638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z; Mei Y; Liu X; Zhou M
    Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of an ErbB3- and ErbB4-specific ligand screening system, and a screen of neuregulin-1 mutants].
    Qi Y; Wei DZ; Liu XF; Zhou MD
    Yi Chuan; 2010 Dec; 32(12):1247-55. PubMed ID: 21513150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study.
    Chow NH; Liu HS; Yang HB; Chan SH; Su IJ
    Virchows Arch; 1997 Jun; 430(6):461-6. PubMed ID: 9230911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
    Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
    Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
    Mill CP; Gettinger KL; Riese DJ
    Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the Neuregulin 1/ErbB system after skeletal muscle denervation and reinnervation.
    Morano M; Ronchi G; Nicolò V; Fornasari BE; Crosio A; Perroteau I; Geuna S; Gambarotta G; Raimondo S
    Sci Rep; 2018 Mar; 8(1):5047. PubMed ID: 29568012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to ERBB3-Directed Targeted Therapy in
    Drilon A; Somwar R; Mangatt BP; Edgren H; Desmeules P; Ruusulehto A; Smith RS; Delasos L; Vojnic M; Plodkowski AJ; Sabari J; Ng K; Montecalvo J; Chang J; Tai H; Lockwood WW; Martinez V; Riely GJ; Rudin CM; Kris MG; Arcila ME; Matheny C; Benayed R; Rekhtman N; Ladanyi M; Ganji G
    Cancer Discov; 2018 Jun; 8(6):686-695. PubMed ID: 29610121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.